凉血化瘀明目汤治疗RVO合并ME的临床疗效
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:


Clinical curative effect of Liangxue Huayu Mingmu Decoction in RVO combined with ME
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
    摘要:

    目的:探究凉血化瘀明目汤治疗视网膜静脉阻塞(RVO)合并黄斑水肿(ME)的临床疗效。方法:选取80例(80只眼)RVO合并ME患者为研究对象,按照治疗方式不同分为实验组和对照组,每组各40例。对照组患者给予玻璃体注射雷珠单抗治疗;实验组患者在对照组基础上加用凉血化瘀明目汤治疗,疗程均为4周。比较两组患者中医证候疗效、治疗期间不良反应及视力改变情况。结果:实验组中医证候疗效高于对照组(P<0.05)。治疗1、2、4周后,实验组患者各时间点最小分辨角(LogMAR)、黄斑中心厚度(CMT)、眼压均低于对照组(P<0.05)。治疗4周后,实验组患者视野平均偏差和视野指数高于对照组(P<0.05)。两组患者治疗期间不良反应发生率比较,差异无统计学意义(P>0.05)。结论:凉血化瘀明目汤联合玻璃体注射雷珠单抗治疗RVO合并ME患者,能提高临床疗效,改善患者视力和视野缺损情况,促进黄斑水肿消退,控制眼压,且安全性良好。

    Abstract:

    Objective:To explore the clinical curative effect of Liangxue Huayu Mingmu Decoction in retinal vein obstruction(RVO)combined with macular edema(ME).Methods:A total of 80 patients(80 eyes)with RVO and ME were included in the study,and they were divided into experimental group and control group according to different treatment methods,with 40 cases in each group.The control group was given intravitreal injection of ranibizumab,while experimental group was treated with Liangxue Huayu Mingmu Decoction on basis of control group for 4 weeks.The curative effect on TCM syndromes,adverse reactions during treatment and changes of visual acuity were compared between the two groups.Results:The curative effect on TCM syndromes in experimental group was better than that in control group(P<0.05).After 1,2 and 4 weeks of treatment,LogMAR,CMT and intraocular pressure in exper-imental group were lower than those in control group(P<0.05).After 4 weeks of treatment,the mean deviation of visual field and vis-ual field index in experimental group were higher than those in control group(P<0.05).There was no significant difference in the in-cidence of adverse reactions between the two groups during treatment(P>0.05).Conclusion:Liangxue Huayu Mingmu Decoction combined with intravitreal injection of ranibizumab can improve clinical curative effect,visual acuity and visual field defect,promote ME regression and control intraocular pressure in patients with RVO and ME,which has good safety.

    参考文献
    相似文献
    引证文献
引用本文

李利侠;杨富华;.凉血化瘀明目汤治疗RVO合并ME的临床疗效[J].川北医学院学报,2025,40(5):664-667.

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-07-09
  • 出版日期:
文章二维码